SEC Company Response from IGC Pharma, Inc. (IGC) (CIK 0001326205) (IGC) — Mar 2, 2006
IGC Pharma, Inc. (IGC) (CIK 0001326205)
Date: March 2, 2006 · CIK: 0001326205 · Accession: 0000950137-06-002481
AI Filing Summary & Sentiment
Show Raw Text
CORRESP
1
filename1.htm
corresp
Ferris Baker Watts Incorporated
100 Light Street
Baltimore, MD 21202
February 27, 2006
United States and Exchange Commission
Mail Stop 0407, 450 Fifth Street, N.W.
450 Fifth Street, N.W.
Washington, D.C. 20549-0405
Re: India Globalization Capital, Inc. Preliminary Prospectus Distribution
Gentlemen:
In
accordance with the provisions of Rule 460 under the Securities
Act of 1933, the undersigned, as representative of the underwriters
of the proposed offering of securities of India Globalization Capital,
Inc. hereby advises that copies of the Preliminary Prospectus, dated
February 13, 2006, were distributed on or after
February 13, 2006, as
follows:
300 to Individual Investors;
3600 to NASD members (which included 14 prospective underwriters and
selected dealers); and
60 to institutions
The undersigned has been informed by the participating dealers that
in accordance with the Rule 15c2-8 under the Securities Exchange Act
of 1934, copies of the Preliminary Prospectus, dated February 13,
2006, have been distributed to all persons to whom it is expected that
confirmations of sale will be sent; and we have likewise so
distributed copies to all customers of ours. We have adequate equity
to underwrite a “firm commitment” offering.
Very truly yours,
Ferris, Baker Watts Incorporated
By:
/s/ Scott T. Bass
Scott T. Bass
Vice President